Saba Labs Overview

  • Founded
  • 2014
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $250K
Latest Deal Amount

Saba Labs General Information


Developer of wound care products designed to treat chronic wounds. The company's wound care products help doctors to treat patients who are suffering from complex, chronic or acute wounds such as surgical site infections, diabetic foot ulcers, venous leg ulcers, pressure ulcers and burns, enabling patients to recover wounds and prevent infection on wound sites.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Services
Primary Office
  • 2501 20th Place South
  • Suite 275
  • Birmingham, AL 35223
  • United States
+1 (205) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Saba Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 27-Jul-2017 $250K 00.000 Completed Startup
4. Angel (individual) 01-Jan-2016 00000 00.000 Completed Startup
3. Angel (individual) 23-Aug-2016 Cancelled Startup
2. Convertible Debt 01-Sep-2015 $850K $2.08M Completed Startup
1. Convertible Debt 29-May-2014 $1.23M $1.23M Completed Startup
To view Saba Labs’s complete valuation and funding history, request access »

Saba Labs Executive Team (2)

Name Title Board Seat Contact Info
Robert Jacobus Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Saba Labs Board Members (4)

Name Representing Role Since
Hossein Dovlatabadi Saba Labs Board Member 000 0000
Madding King III Brookline Group Board Member 000 0000
William Legg Jr. Saba Labs Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »